Nuveen’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$302M Buy
3,490,168
+630,673
+22% +$60.4M 0.08% 193
2025
Q4
$275M Sell
2,859,495
-9,499
-0.3% -$923K 0.07% 215
2025
Q3
$273M Sell
2,868,994
-144,982
-5% -$13.3M 0.07% 218
2025
Q2
$263M Buy
3,013,976
+113,366
+4% +$9.61M 0.07% 219
2025
Q1
$261M Sell
2,900,610
-644,409
-18% -$57.7M 0.08% 217
2024
Q4
$283M Sell
3,545,019
-841,283
-19% -$72.8M 0.08% 208
2024
Q3
$396M Sell
4,386,302
-1,306,354
-23% -$110M 0.11% 158
2024
Q2
$448M Buy
5,692,656
+801,394
+16% +$65.7M 0.13% 133
2024
Q1
$426M Sell
4,891,262
-205,235
-4% -$17.5M 0.13% 142
2023
Q4
$420M Sell
5,096,497
-1,013,155
-17% -$77.2M 0.14% 136
2023
Q3
$479M Sell
6,109,652
-33,971
-0.6% -$2.84M 0.17% 122
2023
Q2
$541M Buy
6,143,623
+48,774
+0.8% +$4.2M 0.19% 107
2023
Q1
$491M Sell
6,094,849
-1,334,615
-18% -$109M 0.18% 113
2022
Q4
$577M Sell
7,429,464
-1,261,240
-15% -$102M 0.22% 103
2022
Q3
$702M Buy
8,690,704
+237,001
+3% +$21.3M 0.28% 78
2022
Q2
$759M Buy
8,453,703
+16,391
+0.2% +$1.66M 0.29% 74
2022
Q1
$918M Sell
8,437,312
-1,243,822
-13% -$131M 0.3% 66
2021
Q4
$1B Sell
9,681,134
-3,312,308
-25% -$384M 0.3% 65
2021
Q3
$1.63B Sell
12,993,442
-220,492
-2% -$28.5M 0.5% 31
2021
Q2
$1.64B Buy
13,213,934
+143,325
+1% +$18M 0.49% 29
2021
Q1
$1.54B Buy
13,070,609
+2,735,614
+26% +$321M 0.49% 31
2020
Q4
$1.21B Buy
10,334,995
+2,707,993
+36% +$298M 0.41% 42
2020
Q3
$793M Buy
7,627,002
+955,250
+14% +$95.9M 0.3% 70
2020
Q2
$612M Sell
6,671,752
-333,952
-5% -$32M 0.25% 84
2020
Q1
$632M Buy
7,005,704
+202,760
+3% +$21.6M 0.31% 71
2019
Q4
$772M Sell
6,802,944
-218,755
-3% -$24M 0.29% 67
2019
Q3
$763M Sell
7,021,699
-1,136,167
-14% -$119M 0.31% 64
2019
Q2
$794M Buy
8,157,866
+8,094,852
+12,846% +$739M 0.31% 59
2019
Q1
$5.74M Sell
63,014
-198
-0.3% -$17.7K 0.03% 484
2018
Q4
$5.75M Sell
63,212
-244
-0.4% -$22.8K 0.04% 468
2018
Q3
$6.24M Sell
63,456
-1,363
-2% -$126K 0.03% 490
2018
Q2
$5.55M Buy
64,819
+697
+1% +$58.2K 0.03% 473
2018
Q1
$5.14M Buy
64,122
+1,535
+2% +$127K 0.03% 479
2017
Q4
$5.05M Sell
62,587
-641
-1% -$51.3K 0.03% 470
2017
Q3
$4.92M Sell
63,228
-478
-0.8% -$39.7K 0.03% 486
2017
Q2
$5.65M Sell
63,706
-40,967
-39% -$3.45M 0.04% 492
2017
Q1
$8.43M Sell
104,673
-175,178
-63% -$13.7M 0.05% 449
2016
Q4
$19.9M Sell
279,851
-313,371
-53% -$24.6M 0.1% 241
2016
Q3
$51.3M Sell
593,222
-18,212
-3% -$1.59M 0.3% 80
2016
Q2
$53.1M Sell
611,434
-143,434
-19% -$11.6M 0.33% 64
2016
Q1
$56.6K Sell
754,868
-28,429
-4% -$2.14M 0.3% 57
2015
Q4
$60.3K Sell
783,297
-66,570
-8% -$5.01M 0.31% 58
2015
Q3
$56.9K Buy
849,867
+105,716
+14% +$7.79M 0.32% 54
2015
Q2
$55.1K Sell
744,151
-125,571
-14% -$9.59M 0.3% 73
2015
Q1
$67.8M Buy
869,722
+651,999
+299% +$49.4M 0.37% 49
2014
Q4
$15.7M Sell
217,723
-114,704
-35% -$7.97M 0.09% 298
2014
Q3
$20.6M Sell
332,427
-4,677
-1% -$297K 0.13% 220
2014
Q2
$21.5M Buy
337,104
+112,380
+50% +$6.83M 0.13% 211
2014
Q1
$13.8M Sell
224,724
-41,567
-16% -$2.42M 0.08% 298
2013
Q4
$15.3M Buy
266,291
+60,056
+29% +$3.41M 0.1% 279
2013
Q3
$11M Buy
206,235
+98,324
+91% +$5.29M 0.07% 336
2013
Q2
$5.55M Buy
+107,911
New +$5.33M 0.04% 482

Other funds holding MDT

Nuveen's MDT Position: Q1 2026 in Review

Nuveen increased its Medtronic (MDT) stake by 22% in Q1 2026, buying an estimated $60.4M and bringing the position to 3,490,168 shares worth $302M. The position accounts for 0.08% of the portfolio, ranked #193.

Nuveen first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.64B in Q2 2021. 2,234 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Nuveen held 3,490,168 shares of Medtronic worth $302M as of Q1 2026.
  • Nuveen bought 630,673 Medtronic shares in Q1 2026, an estimated $60.4M.
  • Medtronic made up 0.08% of Nuveen's portfolio in Q1 2026, its #193 holding.
  • Nuveen first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's Medtronic position peaked at $1.64B in Q2 2021.
  • 2,234 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.